Heron Therapeutics (AXD2) Revenue

4 Followers

Heron Therapeutics Revenue

Heron Therapeutics had a revenue of 37.67M in the quarter ending Jun 30, 2026, with 8.51%. This bring the company's revenue in the last twelve months to 151.18M, Decreased 0.31%. In the fiscal year ending Dec 31, 2025, Heron Therapeutics had annual revenue of 154.90M with 7.36% growth.

Revenue (ttm)

151.18M

Revenue Growth

-5.98%

P/S Ratio

0.33

Revenue/Employee

€1,210,188

Employees

128

Market Cap

€51.62M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	154.90M	10.62M	+7.36%
Dec 31, 2024	144.28M	17.24M	+13.57%
Dec 31, 2023	127.04M	19.37M	+17.99%
Dec 31, 2022	107.67M	21.33M	+24.70%
Dec 31, 2021	86.35M	-2.29M	-2.59%
Dec 31, 2020	88.64M	-57.33M	-39.28%
Dec 31, 2019	145.97M	68.49M	+88.41%
Dec 31, 2018	77.47M	46.71M	+151.81%
Dec 31, 2017	30.77M	―	―